# Eydis Bio, Inc.

Canonical: https://abierto.us/vendors/eydis-bio-inc-mwwcm7jmbcf1

- UEI: MWWCM7JMBCF1
- CAGE: 88U01
- Location: Durham, NC
- Awards in window: 1 (2 transactions), $499,825 obligated, September 29, 2025 to September 2, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, $499,825

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $499,825

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N93025C00040 (definitive contract): $499,825, National Institutes of Health Niaid. Perform a Structure Activity Relationship (Sar), Molecular Binding and Metabolism of the Lead Scaffold (HS-176) to Guide the Development of More Potent and Drug Like Analogs, and Prioritization of Lead Analogs Through in Vitro Efficacy Screening and. https://www.usaspending.gov/award/CONT_AWD_75N93025C00040_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/eydis-bio-inc-mwwcm7jmbcf1.